Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been described as novel biomarkers for the detection and management of diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus over the past few decades.
Market Dynamics
Increasing approval of novel glycated albumin products by key players in the market is expected to drive global glycated albumin kits/assays market growth in the near future. For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Japan-based Asahi Kasei Pharma Corporation for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L).
Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin products, which can be used for the diagnosis/ detection of different types of diabetes such as type 1, and type 2 diabetes. For instance, according to the data published by the American Diabetes Associations in 2015, diabetes is the 7th leading cause of death in the U.S., where around 30.3 million people in the U.S. are suffering from diabetes. Among these, around 193,000 people in the U.S. below the age of 20 are suffering from diabetes.
Key features of the study:
This report provides in-depth analysis of glycated albumin market and provides market size (US$ Million) and cumulative annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global glycated albumin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global glycated albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the glycated albumin market
Detailed Segmentation:
Global Glycated Albumin Market, By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
Global Glycated Albumin Market, By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
Global Glycated Albumin Market, By End User:
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
Global Glycated Albumin Market, By Geography:
North America
By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
By End User
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
By Country:
U.S.
Canada
Europe
By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
By End User
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
By End User
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
By End User
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
By End User
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type :
Human Glycated Albumin
Animal Glycated Albumin
By Application:
Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
Research
By End User
Hospitals/Clinics
Diagnostic Centers
Research Institutes
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Asahi Kasei Pharma Corporation *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Lifespan Biosciences
Biomatik Corporation
Abbexa Ltd.
G Biosciences
DRG International, Inc.
Amsbio LLC
Signalway Antibody LLC
United States Biological
Diazyme Laboratories
Abnova Corporation
Maccura Biotechnology Co. Ltd.
Exocell Inc.
Biorbyt Ltd.
Epinex Diagnostics Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Product Type
o Market Snippet, By Application
o Market Snippet, By End User
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Product Launch
o Importance of Glycated Albumin
o Regulatory Scenario
o PEST Analysis
o Porter's Five Forces Analysis
4. Global Glycated Albumin Market, By Product Type, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Human Glycated Albumin
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Segment Trends
o Animal Glycated Albumin
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
5. Global Glycated Albumin Market, By Application, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Diagnosis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Segment Trends
o Prediabetes
o Type 1 Diabetes
o Type 2 Diabetes
o Research
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
6. Global Glycated Albumin Market, By End User, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Hospitals/Clinics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Diagnostic Centers
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Research Institutes
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
7. Global Glycated Albumin Market, By Region, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017-2026
o North America
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of APAC
o Latin America
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
o Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o GCC
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Asahi Kasei Pharma Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Lifespan Biosciences
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Biomatik Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Abbexa Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o G Biosciences
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o DRG International, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Amsbio LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Signalway Antibody LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o United States Biological
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Diazyme Laboratories
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Abnova Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Maccura Biotechnology Co. Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Exocell Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Biorbyt Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Epinex Diagnostics Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 35 market data tables and 32 figures on "Glycated Albumin Market - Global forecast to 2026".
Request Discount 
Inquire Before Buy
